Disfluent speech in patients with partial epilepsy: Beneficial effect of levetiracetam
Authors:
- GianPietro SechiGSGianPietro Sechi
- Giovanni A. CoccoGCGiovanni A. Cocco
- Marina D’onofrioMDMarina D’onofrio
- Maria G. DeriuMDMaria G. Deriu
- Giulio RosatiGRGiulio Rosati
- 1 November 2006
- journal article
- clinical trial
- Published by Elsevier in Epilepsy & Behavior
- Vol. 9 (3) , 521-523
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Stuttered and fluent speech production: An ALE meta‐analysis of functional neuroimaging studiesHuman Brain Mapping, 2005
- The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetamProceedings of the National Academy of Sciences, 2004
- Stuttering relieved by divalproex sodiumNeurology, 2003
- Evaluation of Neuropsychological Domain Scores and Postural Stability Following Cerebral Concussion in SportsClinical Journal of Sport Medicine, 2003
- Topiramate and word-finding difficulties in patients with epilepsyNeurology, 2003
- Improvement of a patient with stuttering on levetiracetamNeurology, 2002
- Anomalous anatomy of speech–language areas in adults with persistent developmental stutteringNeurology, 2001
- An Open-Label Trial of Bromocriptine in Nonfluent Aphasia: A Qualitative Analysis of Word Storage and RetrievalBrain and Language, 2000
- Drug-Induced StutteringJournal of Clinical Psychopharmacology, 1998
- Acquired stutteringJournal of Fluency Disorders, 1990